From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Topics>
  3. Osteoporosis/Bone Disease

Osteoporosis/Bone Disease

The latest information on bone disease, back and neck pain, osteoporosis, bisphosphonates, and more, drawn from across the Journal Watch specialties. Sign up now for monthly e-mail alerts on new content.

TOP STORY

New Approach to Prevention of Osteoporotic FracturesFree

Clinical calculators can help clinicians determine when patients should start receiving osteoporosis therapy.

SUMMARY AND COMMENT

Falls After Age 90: Inability to Get Up and Prolonged Time on Floor Portend Poor Outcomes

Many elders with access to alarm systems did not use them.

SUMMARY AND COMMENT

Calcium Supplementation in Healthy Nonosteoporotic MenFree

Calcium supplementation is not just for women.

SUMMARY AND COMMENT

A Broken Wrist Might Not Mean Fragile Bones

Women who sustained wrist fractures had elevated risk for recurrent fractures, but the risk was less than that associated with other fragility fractures.

SUMMARY AND COMMENT

Long-Term Growth and Bone Mineralization in Preterm Children

Low bone mineralization persists up to age 9 years in children who were born preterm with low birth weight.

SUMMARY AND COMMENT

Predictors of Bone Loss in HIV-Infected Patients

Tenofovir and ddI use were each associated with accelerated loss of bone mineral density over time; weight training was protective against loss.

SUMMARY AND COMMENT

Monitor Bone Density Carefully After Bariatric SurgeryFree

BMD and serum calcium levels dropped following bariatric surgery in morbidly obese men and women.

SUMMARY AND COMMENT

Zoledronic Acid for Preventing Bone Loss in Young Breast Cancer Patients

Intravenous bisphosphonate prevented loss of BMD associated with chemotherapy.

LETTER TO READERS

Change in Bone and Joint Disease E-mail AlertFree

  • General Medicine

Dear Readers,

SUMMARY AND COMMENT

Proton-Pump Inhibitors and Osteoporosis-Related Fracture

Use of PPI therapy for 7 years or longer is associated with excess risk for osteoporosis-related fractures.

Read more Osteoporosis/Bone Disease articles >>

Search

Advanced

Sign-In

Forgot your password?

New to Journal Watch?

Browse arrow

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Copyright © 2009. Massachusetts Medical Society. All rights reserved.